Arch Biopartners Stock Market Value
| ARCH Stock | CAD 1.95 0.01 0.51% |
| Symbol | Arch |
Arch Biopartners Price To Book Ratio
Arch Biopartners 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arch Biopartners' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arch Biopartners.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Arch Biopartners on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Arch Biopartners or generate 0.0% return on investment in Arch Biopartners over 30 days. Arch Biopartners is related to or competes with NervGen Pharma, Nanalysis Scientific, Perimeter Medical, and Medicenna Therapeutics. Arch Biopartners Inc., a biotechnology company, develops technologies for improving the health of patients More
Arch Biopartners Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arch Biopartners' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arch Biopartners upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.61 | |||
| Information Ratio | 0.1375 | |||
| Maximum Drawdown | 14.5 | |||
| Value At Risk | (3.43) | |||
| Potential Upside | 5.33 |
Arch Biopartners Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arch Biopartners' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arch Biopartners' standard deviation. In reality, there are many statistical measures that can use Arch Biopartners historical prices to predict the future Arch Biopartners' volatility.| Risk Adjusted Performance | 0.1515 | |||
| Jensen Alpha | 0.4632 | |||
| Total Risk Alpha | 0.0487 | |||
| Sortino Ratio | 0.1413 | |||
| Treynor Ratio | 1.92 |
Arch Biopartners Backtested Returns
Arch Biopartners appears to be risky, given 3 months investment horizon. Arch Biopartners secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2% return per unit of standard deviation over the last 3 months. By analyzing Arch Biopartners' technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please makes use of Arch Biopartners' risk adjusted performance of 0.1515, and Mean Deviation of 2.0 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Arch Biopartners holds a performance score of 15. The firm shows a Beta (market volatility) of 0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Arch Biopartners' returns are expected to increase less than the market. However, during the bear market, the loss of holding Arch Biopartners is expected to be smaller as well. Please check Arch Biopartners' market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Arch Biopartners' price patterns will revert.
Auto-correlation | -0.31 |
Poor reverse predictability
Arch Biopartners has poor reverse predictability. Overlapping area represents the amount of predictability between Arch Biopartners time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arch Biopartners price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Arch Biopartners price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Arch Biopartners lagged returns against current returns
Autocorrelation, which is Arch Biopartners stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arch Biopartners' stock expected returns. We can calculate the autocorrelation of Arch Biopartners returns to help us make a trade decision. For example, suppose you find that Arch Biopartners has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Arch Biopartners regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arch Biopartners stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arch Biopartners stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arch Biopartners stock over time.
Current vs Lagged Prices |
| Timeline |
Arch Biopartners Lagged Returns
When evaluating Arch Biopartners' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arch Biopartners stock have on its future price. Arch Biopartners autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arch Biopartners autocorrelation shows the relationship between Arch Biopartners stock current value and its past values and can show if there is a momentum factor associated with investing in Arch Biopartners.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arch Stock Analysis
When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.